Browse > Article

A Survey on Attitude and Awareness of Health-Care Professionals Regarding Pharmacovigilance System and Experience for Adverse Drug Reaction (ADR) from a Single University Hospital  

Kyung, Eun Jung (College of Pharmacy, Chungnam National University)
Rew, Ji Hyun (College of Pharmacy, Chungnam National University)
Oh, Mina (Department of Pharmacy, St. Mary's Hospital)
Kim, Eun Young (College of Pharmacy, Chung-Ang University)
Publication Information
Korean Journal of Clinical Pharmacy / v.23, no.3, 2013 , pp. 256-268 More about this Journal
Abstract
Objective: To study the attitudes and awareness of healthcare professionals (physicians, pharmacists, nurses and others) toward the Pharmacovigilance system and experience for adverse drug reactions (ADRs) from a Single University Hospital in Deajeon. Methods: A survey was performed using a structured questionnaire involving 360 health-care professionals at the hospital between $1^{st}$ November and $16^{th}$ November, 2012. Results: Sixty-five percent (n=235) of all respondents were experienced incidences of ADRs for their patients and 55.8% (n=201) knew the ADR Spontaneous Reporting System in the hospital. However, three-fourths (n=273, 75.8%) of respondents did not know the existence of the Korean Association of Regional Pharmacovigilance Centers (KARP) and 61.7% (n=222) were unaware of the obligation of ADR report from KFDA in cases of serious ADRs. About 83% (n=299) answered that the electronic ADR report system of the hospital was helpful while their work and most (n=336, 93.3%) agreed on the necessaries of the promotion and education about ADR. Conclusion: Seventy-five percent (n=271) of respondents wanted to continue the work for evaluation and feedback for ADRs reported in the hospital. However, the barriers to reporting ADR were; inconvenient ADR reporting system and the lack of time to report ADRs. This study showed that the easier ADR reporting system and education and promotion about ADRs for health-care providers are needed to improve the ADR reporting.
Keywords
Adverse drug reaction; Pharmacovigilance; ADR reporting system; Drug monitoring system; Drug safety;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Bennett CL, Nebeker JR, Yarnold PR, et al., Evaluation of serious adverse drug reaction. Arch Intern Med 2007; 167: 1041-49.   DOI
2 Moore TJ, Cohen MR, Furberg CD. Serious adverse events reported to the Food and Drug Administration, 1995-2005. Arch Intern Med 2007; 167: 1752-59.   DOI
3 Website. Available at http://www.nso.go.kr.
4 DICKSON, M. & JACOBZONE, S. Pharmaceutical use and expenditure for cardiovascular disease and stroke: A study of 12 OECD countries. Paris, Organisation for Economic Co-operation and Development. 2003.
5 KUIJPERS, M. A. J., VAN MARUM, R. J., et al., Relationship between polypharmacy and underprescribing. British Journal of Clinical Pharmacology 2007; 65: 130-3.
6 WIEDENMAYER, K. Rational use of medicines. IN ANDERSON, S., HUSS, R., SUMMERS, R. & WIEDENMAYER, K.(Eds.) Managing pharmaceuticals in international health. Basel, Birkhauser 2004; 141-52.
7 WINDMEIJER, F., DE LAAT, E., DOUVEN, R, et al., Pharmaceutical promotion and GP prescription behaviour. Heath Economics 2006; 15: 5-18.   DOI
8 Roughead E, Pratt N, Peck R, et al., Improving medication safety: influence of a patient-specific prescriber feedback program on rate of medication reviews performed by Australian general medical practitioners. Pharmacoepidemiol Drug Saf 2007; 16: 797-803.   DOI
9 Korea Food and Drug Administration[internet]. Announcement of drug safety information surveillance. [cited 2008 Jun 30] Available from: http://kfda.go.kr [accessed 2012 Nov 27]
10 Kim HK, Kim YS, Pak YG. A Survey on introduction of pharmacovigilance specialist certification system. Journal of pharmacoepidemiology and risk management 2010; 3: 36-45.
11 Figuerias A, Herdeiro MT, Polonia J, et al., An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA 2006; 296: 1086-93.   DOI
12 Kelly M, Kaye KI, Davis SR, et al., Factors influencing adverse drug reaction reporting in New South Wlaes teaching hospitals. Drug Saf 2004; 22: 161-8.
13 World Health Organization: Safety of Medicines: A guide to detecting and reporting adverse drug reactions. WHO, EDM, QSM, 2002.
14 Davies EC, Green CF, Taylor S, et al., Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One. 2009; 4: e4439.   DOI
15 Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash) 2001; 41(2): 192-9.
16 Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug Monitoring, EQUUS: Safety Monitoring of Medicinal Products Guidelines for setting up and running a Pharmacovigilance Centre. London, 2000.
17 Nissen SE, K W. Rosiglitazone Revisited: An Updated Meta-analysis of Risk for Myocardial Infarction and Cardiovascular Mortality. Arch Intern Med 2010; 170: 1191-201.
18 Rhew KY, Lee S. Analysis of the Korea Food and Drug Administration Adverse Drug Reaction Reports. Kor J Clin Pharm 2011; 21(2): 138-44.
19 Choi YH, Sohn UD. The Surveillance of Adverse Drug Reaction (ADR) Reported. Kor J Clin Pharm 2003; 13(2): 72-81.
20 Lim HR, Park EH. Analysis of ADR Reporting Types in Yonsei University Healthcare System. J. Kor. Soc. Health- Syst. Pharm 2011; 28(2): 127-35.
21 Rhew KY, Cho HK, Lee S. Characteristics of Cardiovascular Adverse Drug Reactions Reported to KFDA. Kor J Clin Pharm 2012; 22(1): 41-6.